ONCOLYTICS BIOTECH INC
ONCY
ONCY was delisted on the 4th of November, 2015.
3 hedge funds and large institutions have $12K invested in ONCOLYTICS BIOTECH INC in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
62% more capital invested
Capital invested by funds: $7.41K → $12K (+$4.59K)
57% less funds holding
Funds holding: 7 → 3 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFG
Next Financial Group
Houston,
Texas
|
-$4K |
| 2 |
CS
Credential Securities
Vancouver,
|
-$411 |
ONCY Hedge Fund Activity: Q1 2016 in Review
3 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q1 2016, worth a combined $12K — up 62% from $7.41K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ONCY and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Stifel Financial, opening a new position worth an estimated $8K. The largest seller was Next Financial Group, exiting entirely with an estimated $4K sold.
- 3 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q1 2016, down from 7 in Q4 2015.
- Funds reported $12K of ONCOLYTICS BIOTECH INC stock for Q1 2016, up 62% quarter-over-quarter.
- 1 fund opened new ONCOLYTICS BIOTECH INC positions in Q1 2016 and 5 closed out, a net change of -4 holders.
- The largest ONCOLYTICS BIOTECH INC buyer in Q1 2016 was Stifel Financial, an estimated $8K added.
- The largest ONCOLYTICS BIOTECH INC seller in Q1 2016 was Next Financial Group, an estimated $4K sold.
Based on aggregated 13F filings for Q1 2016.